FAM83D在胰腺癌中的表达及临床意义

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (1304 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the expression and clinical significance of FAM83D in pancreatic adenocarcinoma (PAAD) tissues. Methods The gene expression and prognosis of FAM83D were analyzed online by Gene Expression Profiling Interactive Analysis (GEPIA) tool, and verified by KMplot database; 60 pairs of paraffin blocks were selected after PAAD operation in the Department of Pathology, Yijishan Hospital, Wannan Medical College from January 2018 to December 2019, including cancer tissues and adjacent tissues, and immunohistochemistry (IHC) was used to detect the expression of FAM83D protein; the mechanism of FAM83D was analyzed by gene set enrichment analysis. Results Compared with normal tissues, the expression of FAM83D mRNA was significantly increased in tumor tissues (P < 0.01). Compared with adjacent tissues, IHC score of cancer tissues was significantly higher (P < 0.01). The high expression of FAM83D protein in PAAD patients was associated with lymph node metastasis (P < 0.05). Compared with the low expression of FAM83D mRNA group, the overall survival and progression-free survival in the high expression of FAM83D mRNA group were significantly shorter (P < 0.01). FAM83D up-regulation was positively correlated with multiple gene sets(P < 0.05). Conclusion FAM83D plays an important role in the occurrence and development of PAAD and is expected to become a potential therapeutic target and a novel molecular marker.

Key words： Pancreatic adenocarcinoma FAM83D Prognosis Immunohistochemistry Bioinformatics

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MIAO Yufeng1 ZHANG Youwei2 JIAO Nanlin3

Cite this article:

MIAO Yufeng1 ZHANG Youwei2 JIAO Nanlin3. Expression and clinical significance of FAM83D in pancreatic cancer#br#[J]. 中国医药导报, 2021, 18(32): 9-12,27.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I32/9

[1] 毛铁波，崔玖洁，王理伟.从基础到临床：2019年胰腺癌研究进展[J].中国癌症杂志，2020，30（2）：81-89.
[2] 郑荣寿，孙可欣，张思维，等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志，2019，41（1）：19-28.
[3] 闵永峰，张弛，张波.113例胰腺癌根治术后复发及辅助治疗对生存期影响[J].中华肿瘤防治杂志，2019，26（8）：565-569.
[4] 吕小斌，罗和生.胰腺癌危险因素及其与糖尿病相关性研究进展[J].胃肠病学和肝病学杂志，2020，29（12）：1425-1430.
[5] Santamaria A，Nagel S，Sillje HHW，et al. The spindle protein CHICA mediates localization of the chromokinesin Kid to the mitotic spindle [J]. Curr Biol，2008，18（10）：723-729.
[6] Fulcher LJ，He Z，Mei L，et al. FAM83D directs protein kinase CK1α to the mitotic spindle for proper spindle positioning [J]. EMBO Rep，2019，20（9）：e47495.
[7] Zhang Q，Yu S，Lok SIS，et al. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer [J]. J Cell Mol Med，2019， 23（7）：4569-4581.
[8] Liu X，Gao H，Zhang J，et al. FAM83D is associated with gender，AJCC stage，overall survival and disease-free survival in hepatocellular carcinoma [J]. Biosci Rep，2019，39（5）：BSR20181640.
[9] Shi R，Sun J，Sun Q，et al. Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle [J]. Am J Cancer Res，2016，6（11）：2587-2598.
[10] Yang XX，Ma M，Sang MX，et al. Knockdown of FAM83D enhances radiosensitivity in coordination with irradiation by inhibiting EMT via the Akt/GSK-3β/Snail signaling pathway in human esophageal cancer cells [J]. Onco Targets Ther，2020，13：4665-4678.
[11] 张帆，张伟，焦南林，等.三阴型乳腺癌中CD47的表达及其临床意义[J].临床与实验病理学杂志，2017，33（5）：539-543.
[12] 龚文，刘军，王琳.基于Oncomine数据库分析CXCL5在胰腺癌组织中的表达及临床意义[J].肿瘤预防与治疗，2020，33（7）：578-583.
[13] Bozatzi P，Sapkota GP. The FAM83 family of proteins：from pseudo-PLDs to anchors for CK1 isoforms [J]. Biochem Soc Trans，2018，46（3）：761-771.
[14] Maruthappu T，McGinty LA，Blaydon DC，et al. Recessive mutation in FAM83G associated with palmoplantar keratoderma and exuberant scalp hair [J]. Invest Dermatol，2018，138（4）：984-987.
[15] Cipriano R，Graham J，Miskimen KL，et al. FAM83B mediates EGFR- and RAS-driven oncogenic transformation [J]. J Clin Invest，2012，122（9）：3197-3210.
[16] Richtmann S，Wilkens D，Warth A，et al. FAM83A and FAM83B as prognostic biomarkers and potential new therapeutic targets in NSCLC [J]. Cancers （Basel），2019， 11（5）：652.
[17] Cipriano R，Miskimen KL，Bryson BL，et al. Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer [J]. Mol Cancer Res，2014，12（8）：1156-1165.
[18] Walian PJ，Hang B，Mao JH. Prognostic significance of FAM83D gene expression across human cancer types [J]. Oncotarget，2016，7（3）：3332-3340.
[19] Zhai X，Yang Z，Liu X，et al. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer [J]. Peer J，2020，8：e9975.
[20] 施润.FAM837促进肺癌恶性进展及其机制研究[D].南京：南京医科大学，2017.
[21] Liu X，Gao H，Zhang J，et al. FAM83D is associated with gender，AJCC stage，overall survival and disease-free survival in hepatocellular carcinoma [J]. Biosci Rep，2019，39（5）：BSR20181640.
[22] Wang F，Zhang S，Wei Y，et al. Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/β-catenin signaling and predicts poor prognosis in gastric cancer [J]. Cancer Manag Res，2021，13：3381-3383.
[23] Yin C，Lin X，Wang Y，et al. FAM83D promotes epithelial-mesenchymal transition，invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer [J]. Cell Oncol（Dordr），2020，43（3）：395-407.
[24] Zhu H，Diao S，Lim V，et al. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway [J]. Acta Biochim Biophys Sin（Shanghai），2019，51（5）：509-516.
[25] Mu Y，Zou H，Chen B，et al. FAM83D knockdown regulates proliferation，migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway [J]. Biomed Pharmacother，2017，90：548-554.